CAI vs CPT · rev $812.0M vs P/E 104, rev $5.3M
Caris Life Sciences, Inc. Common Stock (CAI) versus Camden Property Trust (CPT) — a side-by-side from cached financials, not a winner call.
Caris Life Sciences, Inc. Common Stock (CAI) is a biotechnology company listed on NASDAQ.
Camden Property Trust (CPT) is a reit - residential company listed on US.
Latest reported CAI revenue for 2025-12-31 was $812.0M. Net income was -$68.1M. Revenue was up 97.0% from 2024-12-31 to 2025-12-31. CAI currently screens at market cap $5.22B.
Latest reported CPT revenue for 2026-06-30 was $5.3M. Net income was $61.2M. CPT currently screens at market cap $12.11B and trailing P/E 104.0.
CAI currently screens at market cap $5.22B. CPT currently screens at market cap $12.11B and trailing P/E 104.0.
Not investment advice. Open the CAI and CPT stock pages for the full models.
Not investment advice.